The Ingelfinger rule, embargoes, and journal peer review .1.
The Ingelfinger rule, embargoes, and journal peer review .1.
复制标题
DOI：
10.1016/s0140-6736(96)91016-8
复制
发表时间：
1996-05-18
期刊：
影响因子：
168.9
通讯作者：
Altman, LK
中科院分区：
文献类型：
--
作者：
Altman, LK
27年前，弗兰兹·英格尔芬格博士宣布，如果一篇手稿在其他地方发表，他的期刊《新英格兰医学杂志》将拒绝接受。此后，许多其他医学期刊也采用了这一所谓的英格芬格规则。该规则所带来的限制在医学新闻界引起了巨大的争议，正如两部分文章中的第一部分所示，Ingelfinger规则，禁运和期刊同行评审。批评者说，该规则限制了信息的自由流动，而支持者则声称，早期发布的论文中的信息可能是不准确的，因为该论文没有经过同行评审。然而，同行评议本身也受到了审查，其许多局限性很少被公开讨论。
It is 27 years since Dr Franz Ingelfinger announced that a manuscript would be rejected by his journal, the New England Journal of Medicine, if it had been published elsewhere. Many other medical journals have since adopted this so-called Ingelfinger rule. The restrictions resulting from the rule have generated enormous controversy in medical journalism, as shown by the first of the two-part article The Ingelfinger rule, embargoes, and journal peer review. Critics say that the rule restricts the free flow of information, whereas proponents claim that information from a paper released early may be Inaccurate because the paper has not been subjected to peer review. Yet peer review itself has also come under scrutiny, with its many limitations rarely being openly discussed.